Provided by Tiger Trade Technology Pte. Ltd.

Trump Concept

3,183.32
-38.3362-1.19%
Number of Gainers:4
Number of Losers:25
Number of Flat:2
PE:- -
High:3,223.88
Open:3,219.68
Low:3,180.80
Close:3,221.66
Volume:328.68M
Turnover:42.93B
Market Cap:6.03T
Float Cap:5.34T

Loading ...

Market Chatter: FTC to Open Probe Into Anthropic, OpenAI Over Consumer Risks

MT Newswires Live
·
Yesterday

Northrop Grumman Deploys AI-Powered Automation to Speed F-35 Avionics Production, Tighten Quality Control

Reuters
·
Yesterday

US Wants to Speed Certification of New Airplanes

Reuters
·
Yesterday

US Transportation Secretary Duffy Says Federal Aviation Administration Needs to Do More to Speed Certification of New Airplanes

THOMSON REUTERS
·
Yesterday

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Yesterday

Tesla Consensus Sees Q3 2026 Total Deliveries at 461,974 Vehicles

Reuters
·
Yesterday

Ford is Worried About a Labor Shortage and What That Means for Manufacturing

Dow Jones
·
Yesterday

Anthropic's Potential $2 Trillion-Plus IPO Supports Robust AI Infrastructure Spending, Wedbush Says

MT Newswires Live
·
Yesterday

Fortem Technologies Closes $50 Mln Series B Financing Led by Lockheed Martin

Reuters
·
Yesterday

Adding Lilly's New Drug to Zepbound Helped People Lose up to 23% of Their Weight. but There were More Side Effects.

Dow Jones
·
Yesterday

Easa: We Would not Speculate on the Reported Actions or Motivations of the Individuals Involved, or Draw Conclusions About Pilot Fitness or Other Possible Contributing Factors

THOMSON REUTERS
·
Yesterday

European Aviation Safety Agency: Collecting Additional Information from Flydubai and the UAE General Civil Aviation Authority on Today's Incident

THOMSON REUTERS
·
Yesterday

Eli Lilly Says EloraTZP Combo Delivered 'Substantial' Weight Loss, A1C Reduction in Phase 2b Trial

MT Newswires Live
·
Yesterday

Lilly says participants on EloraTZP lost up to average 23.3% of weight in study

TIPRANKS
·
Yesterday

General Motors launches OnStar Fleet Intelligence platform

TIPRANKS
·
Yesterday

Morgan Stanley Currently Down Seven Consecutive Days, on Track for Longest Losing Streak Since January 2024

Dow Jones
·
Yesterday

Lilly's Eloratzp (Combination of Eloralintide and Tirzepatide) Delivered Greater Weight Loss and A1c Reduction VS. Tirzepatide 15 Mg in Adults with Obesity and Type 2 Diabetes

THOMSON REUTERS
·
Yesterday

Eli Lilly: Plans to Initiate Phase 3 Studies of Eloratzp Co-Formulation Product by 2026 End Using Optimized Escalation Schedule

THOMSON REUTERS
·
Yesterday

Eli Lilly: at 48 Weeks, All Combinations of Eloratzp Met Primary & Secondary Endpoints

THOMSON REUTERS
·
Yesterday

Experimental Lilly Combination Drug Tops Zepbound in Weight-Loss Trial

Reuters
·
Yesterday